coronary artery disease - Nursing Case Study
Pathophysiology
• Primary mechanism: Atherosclerosis - Fatty deposits (plaques) build up on artery walls, causing narrowing and reduced blood flow to the heart, leading to ischemia.
• Secondary mechanism: Endothelial dysfunction - Damage to the artery lining impairs its ability to regulate blood flow and maintain vascular tone, exacerbating plaque formation and increasing risk of clotting.
• Key complication: Myocardial infarction - Reduced blood supply can lead to heart tissue death, manifesting as a heart attack, with symptoms like chest pain and shortness of breath.
Patient Profile
Demographics:
67-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia
• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Chest pain and shortness of breath
• Key symptoms: Fatigue, dizziness, occasional palpitations
• Vital signs: Blood pressure 145/90 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 93% on room air
Section 1
New Complications:
As the medical team continues to monitor the patient, additional complications begin to emerge. Despite initial management with medications and oxygen therapy, the patient develops increasing chest discomfort and exhibits diaphoresis. The nursing staff notes that his oxygen saturation has decreased to 89% on room air, prompting the need for supplemental oxygen via nasal cannula. His heart rate increases to 110 bpm, and he appears increasingly anxious, clutching his chest. An ECG is performed, revealing ST-segment elevation in the anterior leads, indicative of an acute myocardial infarction. The presence of elevated troponin levels in the latest lab results confirms myocardial injury, suggesting the progression of coronary artery disease to a more severe stage.
In light of these developments, the healthcare team recognizes the need for urgent intervention to restore coronary blood flow. They prepare to transfer the patient to the cardiac catheterization lab for percutaneous coronary intervention (PCI). During pre-procedure preparation, the nurse ensures the patient is informed about the upcoming procedure, explaining the risks and benefits while providing reassurance. The patient's blood pressure remains elevated at 150/95 mmHg, and he continues to experience palpitations. This situation underscores the importance of addressing both the mechanical blockage and the underlying risk factors, such as hypertension and hyperlipidemia, to prevent further complications.
This critical juncture emphasizes the need for diligent monitoring and timely intervention. The unfolding scenario presents opportunities for clinical reasoning as the team assesses the patient's evolving condition, prioritizes interventions, and anticipates potential complications. As the patient transitions to the cath lab, the focus shifts to the efficacy of PCI and subsequent management strategies to improve cardiac function and mitigate future risks.
Section 2
As the patient is wheeled into the cardiac catheterization lab, the interventional cardiology team promptly initiates the percutaneous coronary intervention (PCI). During the procedure, the angiogram reveals a significant stenosis of the left anterior descending artery, commonly referred to as the "widow maker" due to its critical role in supplying blood to a large portion of the heart. The interventional cardiologist successfully performs angioplasty and deploys a stent to restore blood flow. Throughout the procedure, continuous monitoring of the patient's vital signs indicates a slight improvement in oxygen saturation, now reaching 92% with supplemental oxygen, while his heart rate stabilizes to 98 bpm. However, blood pressure remains slightly elevated at 145/90 mmHg, prompting consideration for further pharmacologic management post-procedure.
Following the PCI, the patient is transferred to the cardiac care unit for close observation and recovery. Repeat ECG results show resolution of the ST-segment elevation, suggesting successful reperfusion of the affected myocardial region. Despite these positive signs, the patient continues to experience mild chest discomfort, which the nursing staff attributes to post-procedural inflammation and the body's response to the intervention. Troponin levels are closely monitored, as they are expected to peak and gradually decline, indicating the natural course of myocardial injury healing. The healthcare team emphasizes the importance of vigilant monitoring for potential complications such as arrhythmias or re-occlusion, which could occur during the critical post-procedure phase.
The patient's clinical journey necessitates further exploration of underlying risk factors contributing to his coronary artery disease. As his condition stabilizes, the healthcare team plans to address lifestyle modifications and initiate secondary prevention strategies. This includes optimizing medication regimens to manage blood pressure and lipid levels, alongside patient education on dietary changes, physical activity, and smoking cessation, as these are pivotal in reducing future cardiovascular events. As the patient recuperates, the focus remains on reinforcing adherence to these interventions to enhance long-term outcomes and quality of life.
Section 3
As the patient settles into the cardiac care unit, the nursing team conducts an initial assessment to establish a baseline for ongoing monitoring. Upon evaluation, the patient is alert and oriented, but continues to report mild chest discomfort, rating it as a 3 on a 10-point scale. He denies any radiation of pain or associated symptoms like shortness of breath or diaphoresis. Vital signs reveal a blood pressure of 140/85 mmHg, heart rate of 92 bpm, respiratory rate of 18 breaths per minute, and oxygen saturation of 94% on 2 liters per minute of nasal cannula. Auscultation of heart sounds is unremarkable, with no murmurs or gallops detected. Lung fields are clear bilaterally, and the patient exhibits no signs of peripheral edema.
As the team reviews the most recent laboratory results, they note a peak in troponin I levels at 8 ng/mL, consistent with myocardial injury, but anticipate a downward trend. Lipid panels reveal elevated LDL cholesterol at 160 mg/dL, further emphasizing the need for aggressive lipid-lowering therapies. The nursing staff observes a new onset of occasional premature ventricular contractions (PVCs) on the cardiac monitor, prompting consultation with the cardiologist to evaluate the potential need for antiarrhythmic treatment. This finding, though not immediately alarming, requires close observation for any progression to more serious arrhythmias.
In response to these developments, the healthcare team adjusts the patient's medication regimen, introducing a beta-blocker to address both blood pressure control and arrhythmia prophylaxis. Additionally, a high-intensity statin is initiated to target the elevated LDL levels. The patient is educated on the importance of these medications and is encouraged to maintain a log of his symptoms and vital signs to facilitate effective communication with the healthcare team. These interventions are designed to optimize his recovery, prevent further complications, and establish a foundation for long-term cardiovascular health. As the patient progresses, the focus will shift to evaluating his response to these interventions and ensuring he remains on the path to recovery.
Section 4
As the nursing team continues to monitor the patient in the cardiac care unit, a slight change in his status is noted during the evening shift. The patient reports a subtle increase in chest discomfort, now rating it as a 5 on a 10-point scale. He also mentions feeling slightly more fatigued than earlier, though he still denies shortness of breath or significant diaphoresis. Upon reassessment, his vital signs reveal a blood pressure of 135/80 mmHg, a heart rate that has increased to 105 bpm, respiratory rate of 20 breaths per minute, and oxygen saturation has slightly decreased to 92% despite continued supplemental oxygen. On auscultation, the heart sounds remain consistent with the previous assessment, yet the frequency of PVCs on the cardiac monitor appears to have increased. The patient has developed mild peripheral edema, noted for the first time, particularly in the lower extremities, raising concerns about possible fluid retention or worsening cardiac function.
In light of these developments, the cardiologist is consulted again. A repeat EKG is ordered, which reveals a pattern of frequent PVCs interspersed with short runs of non-sustained ventricular tachycardia. This finding necessitates a reassessment of the beta-blocker dosage and consideration of adding an additional antiarrhythmic medication to manage the arrhythmias more effectively. Given the presence of peripheral edema, a diuretic is also initiated to address potential fluid overload and prevent further strain on the heart. Furthermore, the healthcare team considers the possibility of an underlying electrolyte imbalance, so serum electrolytes are rechecked, revealing a potassium level at the lower end of normal at 3.5 mEq/L, prompting the introduction of potassium supplementation to support cardiac stability.
The patient's care plan is adjusted to reflect these new interventions, with an emphasis on close monitoring of cardiac rhythms, fluid balance, and electrolyte levels. The nursing staff continues to educate the patient about the importance of adhering to medication regimens and lifestyle modifications, including dietary changes to support better cardiovascular health. The overall goal is to stabilize the patient's condition, reduce the frequency and severity of arrhythmias, and prevent further complications as he remains under observation and treatment in the cardiac care unit.
Section 5
As the nursing team continues to monitor the patient closely, they observe a change in his status the following morning. The patient reports that his chest discomfort has slightly worsened, now rating it as a 6 out of 10. He also notes an increased level of fatigue and mentions experiencing some mild shortness of breath, which had not been present before. His vital signs show a further elevation in heart rate to 112 bpm, while his blood pressure remains steady at 130/78 mmHg. His respiratory rate has increased to 22 breaths per minute and oxygen saturation has decreased slightly to 90%, despite continued use of supplemental oxygen.
In response to these changes, another EKG is performed, which shows a persistent pattern of frequent PVCs and more frequent episodes of non-sustained ventricular tachycardia. The cardiologist is informed, and after reviewing the patient's current medications and recent lab results, decides to adjust the beta-blocker dose further and initiates an antiarrhythmic agent to better control the arrhythmias. Meanwhile, a repeat assessment of the patient's peripheral edema reveals no significant improvement, prompting an increase in the diuretic dosage. The nursing team also closely monitors the patient's fluid intake and output to assess the effectiveness of the diuretic therapy.
The healthcare team emphasizes the importance of continuous monitoring and reassessment in light of these developments. The patient's care plan is updated to include frequent checks of electrolyte levels, particularly potassium, due to its critical role in cardiac function. The patient and his family are provided with detailed education about recognizing symptoms that could indicate worsening heart function and the significance of adhering to the prescribed medication regimen. The goal remains to stabilize the patient's condition, manage symptoms effectively, and prevent further complications.